This multicenter trial will compare giving Stavudine (d4T) to Zidovudine to children infected with HIV who are aged 90-days to 6 years. In particular, the safety of Stavudine and how it is tolerated will be studied. It is hoped Stavudine can be used to control HIV infection and slow the progression of AIDS.
Showing the most recent 10 out of 837 publications